Question 1

Am I eligible for this trial based on my migraine history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE) clinical trial (NCT05550207). Contact the study team or your healthcare provider for specific answers.

Question 2

How does AXS-07 compare to my current migraine treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE) clinical trial (NCT05550207). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of AXS-07?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE) clinical trial (NCT05550207). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE) clinical trial (NCT05550207). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the treatment period?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE) clinical trial (NCT05550207). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE) clinical trial (NCT05550207). Contact the study team or your healthcare provider for specific answers.

Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)

What this study is about

Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)

What this study is about